Skip to main content
. 2001 Oct;45(10):2838–2844. doi: 10.1128/AAC.45.10.2838-2844.2001

TABLE 3.

Activity of cathelicidin peptides against P. aeruginosa, S. maltophilia, and A. xylosoxidans isolated from patients with CF

Peptides P. aeruginosa
S. maltophilia
A. xylosoxidans
MIC range (μg/ml) MIC50 (μg/ml) MIC90 (μg/ml) MIC range (μg/ml) MIC range (μg/ml)
LL37 4–64 32 64 2–32 >32
CAP18 1–32 4 16 2–16 2–32
CAP18-18 1–64 16 64 NTa NT
CAP18-22 0.5–32 4 16 4–32 1–32
mCRAMP 1–64 32 64 4–32 >32
rCRAMP 8–64 32 64 NT NT
SMAP29 0.06–8 1 2 1–8 1–32
OV-1 0.125–16 8 16 NT NT
OV-2 0.03–16 2 4 NT NT
OV-3 1–8 2 4 NT NT
a

NT, not tested. 

HHS Vulnerability Disclosure